Fenwal Inc FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Aug 7, 2017
  • 2 Class I recalls
  • Last warning letter 2016
Inspections 2 0 OAI
Recalls 10 2 Class I (20%)
Warning letters 1 Latest Oct 14, 2016
510(k) clearances 3 Latest Jun 10, 2014

Fenwal Inc has 10 FDA recalls (2 Class I), 2 inspections, 3 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Fenwal Inc, the most recent on Oct 14, 2016.

What these totals cover: FDA records filed under the name "Fenwal Inc" and its spelling variant "Fenwal". They do not include records filed under Fresenius Kabi or other names in its corporate family; those are listed under Related names, each with its own counts.

Latest recall
Z-1255-2023 · Class II · Feb 14, 2023
Latest inspection
Aug 7, 2017 · NAI
Latest 510(k)
Jun 10, 2014

Part of the Fresenius Kabi corporate family.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls10 (2 Class I)Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026Current
510(k) clearances3Nov 22, 2026File dated Nov 18, 2026Current
Inspections2Nov 22, 2026Newest record Nov 9, 2026Current
Compliance actions1Nov 22, 2026Newest record Nov 13, 2026Current

FDA record by year

Fenwal Inc's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Fenwal Inc: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 4 recall records (2 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300020
202200000
202100030
202000000
201900042
201800000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Fenwal Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Fenwal Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Fenwal Inc FDA Warning Letters

1 warning letter on Oct 14, 2016.

IssuedSubjectIssuing officeClose-out letter
Oct 14, 2016 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

10 recall records from May 24, 2013 to Feb 14, 2023.

NumberClassProductDate
Z-1255-2023Class IIAmicus Exchange Kit Therapeutics. Component of Amicus Separator multiprocedural apheresis platformFeb 14, 2023
Z-1254-2023Class IIAmicus MNC Apheresis Kit Double Needle. Component of Amicus Separator multiprocedural apheresis…Feb 14, 2023
Z-1344-2021Class IIAmicus Exchange Kit - Product Usage: intended for use in the collection of blood components and…Feb 25, 2021
Z-1343-2021Class IIAmicus MNC Apheresis Kit - Double Needle - Product Usage: intended for use in the collection of…Feb 25, 2021
Z-1345-2021Class IIAmicus Exchange Kit Therapeutics - Product Usage: intended for use in the collection of blood…Feb 25, 2021
Z-2065-2019Class IVigilant Agilia, Vigilant Drug'Lib, REF Z073476, versions 1.0 and 1.1 Product Usage: Vigilant…Jun 24, 2019
Z-2064-2019Class IVOLUMAT MC AGILIA US, Infusion Pump, REF Z021135, software versions 1.7 and 1.9a Product Usage…Jun 24, 2019
Z-1209-2019Class IIFresenius Kabi CATSmart device (Continuous autotransfusion System). Labeled as the following kits…Mar 5, 2019
Z-1059-2019Class IIVacuum Unit for CATSmart Vacuum Pump. Fresenius CATSmart (Continuous Autotransfusion System) is…Feb 11, 2019
Z-1523-2013Class IIAMICUS Exchange Kit; Product Usage: This kit is designed for use with the AMICUS separator for…May 24, 2013

Recent FDA inspections

2 inspections from Mar 20, 2009 to Aug 7, 2017.

DateSiteProductClassificationFEI
Aug 7, 2017Lake Zurich, ILDevicesNo Action Indicated (NAI)3004548776
Mar 20, 2009Lake Zurich, ILDevicesVoluntary Action Indicated (VAI)3004548776
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Fenwal Inc: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Oct 14, 2016.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3004548776Lake Zurich, IL2Aug 7, 2017

Recent 510(k) clearances

3 510(k) clearances from Mar 3, 2008 to Jun 10, 2014.

K-NumberDeviceDate
K141019AMICUS SEPARATOR SYSTEM/ AMICUS SEPERATOR SYSTEM;REFURBISHEDJun 10, 2014
K111702AMICUS SEPARATOR SYSTEM- USE IN THERAPEUTIC PLASMA EXCHANGE AND FILTER SET FOR AMICUS TPEMar 22, 2012
K073339BLOOD COMPONENT RECIPIENT SET WITH STANDARD SIZE FILTER AND INFUSION SET WITH SIDE ARM LUER…Mar 3, 2008

Fenwal Inc and the FDA: common questions

Has Fenwal Inc received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Fenwal Inc. The most recent is dated Oct 14, 2016.

Has Fenwal Inc received an FDA Form 483?

FDA has not published a Form 483 for "Fenwal Inc" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Fenwal Inc?

The most recent FDA inspection on file ended Aug 7, 2017 at Lake Zurich, IL and was classified NAI. FDA has 2 inspections of Fenwal Inc on file.

Has Fenwal Inc had an FDA recall?

Yes. Fenwal Inc has 10 FDA recalls on record, 2 of them Class I, the most serious class. The most recent started Feb 14, 2023.

Need more than this page shows? Ask about Fenwal Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.